Lakefront Biotherapeutics N.V. (LKFT) earnings

  • Healthcare
  • NASDAQ
  • Market cap$2.2B

Next report

2027-02-24

In 95 daysQ4 FY2026Time not announced· Expected date
EPS consensus
-0.70
Revenue consensus
$7.96M

Latest result

10 days ago

⁦+94.6%⁩

Unusually large: likely a one-off gain or charge, so not comparable with consensus

2026-11-11Q3 FY2026
EPS
Reported / estimate-0.04 / -0.83
Revenue
$8.39M / $7.50M

Stock reaction

Unavailable

Recent quarters

Latest 2 quarters

Revenue and stock reaction

Reported / estimate

  • Q3 FY2026 · 2026-11-11Unavailable
    EPS-0.04 / -0.83+94.6%†
    Revenue$8.39M / $7.50M
  • Q2 FY2026 · 2026-08-10Unavailable
    EPS0.03 / -0.24+114.6%†
    Revenue$14.0M / $6.20M
  • †Unusually large: likely a one-off gain or charge, so not comparable with consensus
  • Estimate recorded after the releaseNo estimate was saved before the results came out, so the surprise is measured against an estimate recorded after the release.

This company reports in EUR, and its reported revenue and the estimate may be in different currencies, so no revenue surprise or dollar sign is shown.

Reaction is the close of the reacting session versus the previous close. The gap to SPY is in percentage points.